Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 875 of 3284 entries
View as:

AZD8566 Food Effect/Microtracer Study

Phase: N/A Priority: Normal
NCT ID: NCT00866385 Org: User:
Start: 03/31/09 End: 04/30/09 Due: 04/30/10

Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILD

Phase: N/A Priority: Normal
NCT ID: NCT06192004 Org: User:
Start: 01/05/24 End: 04/30/25 Due: 04/30/26

Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00233610 Org: User:
Start: 12/31/03 End: 10/31/07 Due: 10/31/08

Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy - PLUS

Phase: N/A Priority: Normal
NCT ID: NCT03918304 Org: User:
Start: 06/11/19 End: 10/27/24 Due: 10/27/25

Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00573222 Org: User:
Start: 11/30/07 End: 05/31/08 Due: 05/31/09

Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort®Respules® in Children Outpatients

Phase: N/A Priority: Normal
NCT ID: NCT00660114 Org: User:
Start: 04/30/08 End: 03/31/09 Due: 03/31/10

Bioequivalence Study Comparing D961H Sachet and D961H Capsule in Japanese Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01595425 Org: User:
Start: 05/31/12 End: 06/30/12 Due: 06/30/13

Symbicort Onset of Action 2

Phase: N/A Priority: Normal
NCT ID: NCT00646009 Org: User:
Start: 03/31/03 End: 08/31/03 Due: 08/31/04

To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole

Phase: N/A Priority: Normal
NCT ID: NCT01397084 Org: User:
Start: 08/31/11 End: 01/31/12 Due: 01/31/13

Faslodex 500mg Multiple Dose Tolerability Study in BC Patients

Phase: N/A Priority: Normal
NCT ID: NCT00328120 Org: User:
Start: 04/30/04 End: 06/30/10 Due: 06/30/11

A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01180400 Org: User:
Start: 09/30/10 End: 09/30/11 Due: 09/30/12

Clinical Outcomes of Exenatide Versus Basal Insulin

Phase: N/A Priority: Normal
NCT ID: NCT02987348 Org: User:
Start: 06/30/15 End: 06/30/15 Due: 06/30/16

The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01608724 Org: User:
Start: 11/30/12 End: 05/31/14 Due: 05/31/15

Utilization Patterns of Pulmicort in Real Life Practice

Phase: N/A Priority: Normal
NCT ID: NCT00660569 Org: User:
Start: 01/31/08 End: 02/28/09 Due: 02/28/10

Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01029886 Org: User:
Start: 01/31/10 End: 04/30/11 Due: 04/30/12

A Single-dose Study to Investigate the Effects of 3 Different Doses of Inhaled AZD2115 in COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT01498081 Org: User:
Start: 03/31/12 End: 10/31/12 Due: 10/31/13

Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT03162055 Org: User:
Start: 05/25/17 End: 05/04/18 Due: 05/04/19

Quetiapine Augmentation in Severe Obsessive Compulsive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00254735 Org: User:
Start: 04/30/02 End: 03/31/06 Due: 03/31/07

A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00357370 Org: User:
Start: 10/31/06 End: 03/31/08 Due: 03/31/09

Characterisation of Patients With Severe Asthma in Primary and Secondary Care Settings in Europe Reported to be Eligible for Biological Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03629782 Org: User:
Start: 04/26/18 End: 07/31/20 Due: 07/31/21

Predictors of Recurrence in Bipolar Disorder in Spain

Phase: N/A Priority: Normal
NCT ID: NCT00690859 Org: User:
Start: 06/30/07 End: 03/31/09 Due: 03/31/10

Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)

Phase: N/A Priority: Normal
NCT ID: NCT00687245 Org: User:
Start: 08/31/06 End: 05/31/08 Due: 05/31/09

A Real-world, Multi-center, Prospective, Observational Study for PNH in China

Phase: N/A Priority: Normal
NCT ID: NCT06154512 Org: User:
Start: 11/10/23 End: 11/30/25 Due: 11/30/26

Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00749970 Org: User:
Start: 07/31/08 End: 01/31/09 Due: 01/31/10

Oral Mucosal Absorption Study of Bicalutamide New Formulation

Phase: N/A Priority: Normal
NCT ID: NCT01416883 Org: User:
Start: 07/31/10 End: 08/31/10 Due: 08/31/11